IMPLANTABLE ARTICLE, METHOD OF FORMING SAME AND METHOD FOR REDUCING THROMBOGENICITY
First Claim
1. An implantable device comprising:
- at least one first degradable layer providing at least one surface of the implantable device for contacting bodily fluid or tissue and disposed about a central core; and
at least one second degradable layer between said first degradable layer and the central core, wherein said first degradable layer has a first degradation rate and said second degradable layer has a second degradation rate such that said at least one first degradable layer degrades more rapidly then said at least one second degradable layer on contact with bodily fluid or tissue.
0 Assignments
0 Petitions
Accused Products
Abstract
Endothelialization of a bodily fluid or tissue-contacting, particularly blood-contacting, surface may be accomplished to render that surface substantially non-thrombogenic. Thrombosis may also be mitigated or eliminated by providing an eroding layer on the surface that results in the removal of any thrombus formation as the layer erodes. An implantable device may utilize at least one surface having a plurality of nano-craters thereon that enhance or promote endothelialization. Additionally, an implantable device may have at least one first degradable layer for contacting bodily fluid or tissue and disposed about a central core, and at least one second degradable layer between the first degradable layer and the central core. The first degradable layer has a first degradation rate and the second degradable layer has a second degradation rate which degrades more slowly than the first degradable layer on contact with bodily fluid or tissue.
-
Citations
15 Claims
-
1. An implantable device comprising:
-
at least one first degradable layer providing at least one surface of the implantable device for contacting bodily fluid or tissue and disposed about a central core; and
at least one second degradable layer between said first degradable layer and the central core, wherein said first degradable layer has a first degradation rate and said second degradable layer has a second degradation rate such that said at least one first degradable layer degrades more rapidly then said at least one second degradable layer on contact with bodily fluid or tissue. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A method of reducing thrombogenicity of an implantable device having at least one surface for contacting bodily fluid or tissue, comprising:
-
providing at least one first degradable layer which provides said at least one surface and which is disposed about a central core, and at least one second degradable layer between said first degradable layer and the central core, wherein said first degradable layer has a first degradation rate and said second degradable layer has a second degradation rate such that said at least one first degradable layer degrades more rapidly than said at least one second degradable layer on contact with bodily fluid or tissue. - View Dependent Claims (9, 10, 11, 12, 13, 14, 15)
-
Specification